Live from the NIH registry
Studies recruiting near Toledo right now
Top 25 of 216 recruiting studies, sorted by proximity — each links to its official registry page
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Taylor Cancer Research Center (site 204) — Maumee, Ohio (7.9 mi)
· Sponsor: VM Oncology, LLC
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Children's Oncology Group
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
University of Toledo — Toledo, Ohio (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: National Cancer Institute (NCI)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: NRG Oncology
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Mercy Health - Saint Anne Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Stepped Approach to Reducing Risk of Suicide in Primary Care
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 2,572 participants sought
Franklin Avenue Primary Care Center — Toledo, Ohio (1.4 mi)
· Sponsor: Cynthia Fontanella
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Cancer Harboring BRAF Alterations, HGG
Phase 2
Interventional 254 participants sought
Toledo Clinic Cancer Center — Toledo, Ohio (1.4 mi)
· Sponsor: Fore Biotherapeutics
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
ProMedica — Toledo, Ohio (1.4 mi)
· Sponsor: Novo Nordisk A/S
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12063 — Toledo, Ohio (1.4 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Children's Oncology Group
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - Alexis — Toledo, Ohio (1.4 mi)
· Sponsor: R1 Therapeutics
Eastern Principles Acceptance and Commitment Therapy For Injury Prevention Among Nurses and Nursing Aides
Well-Being, Psychological, Work Injury
N/A
Interventional 255 participants sought
Bowling Green State University — Bowling Green, Ohio (20.3 mi)
· Sponsor: Bowling Green State University
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: PedAL BCU, LLC
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Taylor Cancer Research Center — Maumee, Ohio (7.9 mi)
· Sponsor: Paradigm Health
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
NSCLC (Non-small Cell Lung Cancer), HNSCC
Phase 1
Interventional 74 participants sought
Site 06 — Maumee, Ohio (7.9 mi)
· Sponsor: TwoStep Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: SWOG Cancer Research Network
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
The University of Toledo — Toledo, Ohio (1.4 mi)
· Sponsor: Tizona Therapeutics, Inc
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Toledo Institute of Clinical Research — Toledo, Ohio (1.4 mi)
· Sponsor: Vedanta Biosciences, Inc.
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Children's Oncology Group
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
Phase 3
Interventional 186 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: Genelux Corporation